Braulio Hernandez - Hodgkin’s Lymphoma

FDA Direct: Removing Black Box Warnings for HRT (Part 2/2)

Fan Ding - Gaucher Disease

Medical Device Quality Management System Regulation Risk Management

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Direct: Catching Up on Agency Reforms

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S06 - (PV): Regulatory Updates

Tobacco Products Scientific Advisory Committee Meeting, October 7, 2025

FDA Direct: Removing Black Box Warnings for HRT (Part 1/2)

Medical Device Quality Management System Regulation Design and Development

FDA Expert Panel on Testosterone Replacement Therapy for Men

Initiating the Removal of the “Black Box Warning” on Hormone Replacement Therapy

Susan Chittooran's Work on Rare Diseases

GCP & Pharmacovigilance Compliance Symposium | D3S03-1 - (BE): Clinical Study Conduct

FDA Direct: FDA Awards Six National Priority Vouchers

2025 FDA Achievements

November 13, 2025: Pediatric Advisory Committee Meeting (PAC)

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S04 - (PV): International...

Public Meeting: Reauthorization of the Biosimilar User Fee Act

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S05 - (PV): Future of...

Good Clinical Practice & Pharmacovigilance Compliance Symposium | D3S03-2 – Q&A Discussion Panel